Connect with us

Fresh World News

Pfizer Inc.’s Lyrica sees 9 generic versions approved by FDA

Pfizer Inc.'s Lyrica sees 9 generic versions approved by FDA

FINANCIAL NEWS

Pfizer Inc.’s Lyrica sees 9 generic versions approved by FDA


TRENTON, N.J. – The U.S. Food and Drug Administration has approved the first generic copies of a popular, pricey pill for nerve pain.

The agency on Monday said it approved nine generic versions of Pfizer Inc.’s Lyrica.

It is also used for seizures and fibromyalgia, a condition that causes chronic, widespread pain.

Lyrica, approved in 2004, is Pfizer’s second bestseller, with sales last year of $4.6 billion.

The heavily advertised drug costs about $460 to $720 per month without insurance, depending on the pharmacy. Prices can vary widely.

Prices for generic versions range from about $140 to $370 per month, according to the drug price comparison site GoodRx.

Common side effects include dizziness, blurred vision and sleepiness. Serious side effects include allergic reactions and life-threatening breathing problems.

Faulty engine part: Volvo issues major 500,000 car recall



Source link

Continue Reading
You may also like...
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

More in FINANCIAL NEWS

To Top
error: Content is protected !!